These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8464648)

  • 41. Pediatric tonsillopharyngitis--an evaluation of cefprozil in Indian patients.
    Gupta N; Mukherjee A; Moharana AK
    Indian J Pediatr; 2004 Jul; 71(7):601-5. PubMed ID: 15280609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cefaclor--summary of clinical experience.
    Kammer RB; Short LJ
    Postgrad Med J; 1979; 55 Suppl 4():93-9. PubMed ID: 548945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical studies on cefprozil granules in pediatrics].
    Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Niinou K
    Jpn J Antibiot; 1992 Nov; 45(11):1514-25. PubMed ID: 1494234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Symposium on antimicrobial therapy. IV. The cephalosporins.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loracarbef: a new orally administered carbacephem antibiotic.
    Force RW; Nahata MC
    Ann Pharmacother; 1993 Mar; 27(3):321-9. PubMed ID: 8453172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
    Gehanno P; Berche P; Boucot I; Lambert-Zechovsky N; Bingen E; Gres JJ; Rollin C
    J Antimicrob Chemother; 1994 Jun; 33(6):1209-18. PubMed ID: 7928814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cefaclor into the millennium.
    Brumfitt W; Hamilton-Miller JM
    J Chemother; 1999 Jun; 11(3):163-78. PubMed ID: 10435677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pediatric experiences with cefamandole nafate].
    Perinotto G; Belloni CL; Robecchi GA; Fiorella G
    Clin Ter; 1981 Apr; 97(2):165-74. PubMed ID: 7237956
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacokinetic and clinical studies of cefprozil fine granules in children].
    Nagano K; Maeda H; Yanagi T; Tsuji Y; Imamura H; Nakayama N; Yanagishima M; Fukuda S
    Jpn J Antibiot; 1992 Dec; 45(12):1736-44. PubMed ID: 1289590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of oral cephalosporins in the treatment of acute otitis media in children.
    Brook I
    Int J Antimicrob Agents; 2004 Jul; 24(1):18-23. PubMed ID: 15225855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.
    Nicolau DP; Sutherland CA; Arguedas A; Dagan R; Pichichero ME
    Paediatr Drugs; 2007; 9(2):119-23. PubMed ID: 17407367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical evaluation of cefprozil granules in pediatric field].
    Furukawa S; Okada T
    Jpn J Antibiot; 1992 Dec; 45(12):1658-62. PubMed ID: 1289584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical evaluation of S-1108 in children].
    Kitamura K; Ihara T; Kamiya H; Azuma E; Ito M; Sakurai M
    Jpn J Antibiot; 1993 Nov; 46(11):1025-9. PubMed ID: 8309065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
    Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
    Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.
    Funk EA; Strausbaugh LJ
    Pharmacotherapy; 1982; 2(4):185-96. PubMed ID: 6221236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical studies on cefprozil granules].
    Haruta T; Tsutsui T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1992 Dec; 45(12):1642-9. PubMed ID: 1289582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacokinetical and clinical study of cefpirome in children].
    Kida K; Morimoto T; Matsuda H; Murase M
    Jpn J Antibiot; 1991 Feb; 44(2):234-40. PubMed ID: 2041162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Laboratory and clinical studies on S-1108 in the pediatric field].
    Akita H; Yokota T; Sunakawa K; Iwata S; Satoh Y
    Jpn J Antibiot; 1993 Nov; 46(11):967-77. PubMed ID: 8309073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibacterial activity of cefprozil in vitro.
    Liu YC; Huang WK; Chen DL
    Chemotherapy; 1995; 41(6):427-32. PubMed ID: 8529432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.